O	0	2	Do
B-intervention	3	12	community
I-intervention	12	13	-
I-intervention	13	18	based
I-intervention	19	26	patient
I-intervention	27	37	assistance
I-intervention	38	46	programs
O	47	53	affect
O	54	57	the
O	58	67	treatment
O	68	71	and
O	72	76	well
O	76	77	-
O	77	82	being
O	83	85	of
O	86	94	patients
O	95	99	with
O	100	106	breast
O	107	113	cancer
O	113	114	?

O	115	123	Patients
O	124	128	with
O	129	135	breast
O	136	142	cancer
O	143	146	who
O	147	151	need
O	152	160	adjuvant
O	161	171	treatments
O	172	177	often
O	178	182	fail
O	183	185	to
O	186	193	receive
O	194	198	them
O	198	199	.

O	200	204	High
O	204	205	-
O	205	212	quality
O	212	213	,
O	214	223	community
O	223	224	-
O	224	229	based
O	230	237	patient
O	237	238	-
O	238	248	assistance
O	249	257	programs
O	258	261	are
O	262	264	an
O	265	274	underused
O	274	275	,
O	276	287	inexpensive
O	288	296	resource
O	297	299	to
O	300	304	help
O	305	313	patients
O	314	318	with
O	319	325	cancer
O	326	332	obtain
O	333	339	needed
O	340	347	therapy
O	347	348	.

O	349	351	We
O	352	358	sought
O	359	361	to
O	362	371	determine
O	372	379	whether
O	380	390	connecting
O	391	396	women
O	397	399	to
O	400	407	patient
O	407	408	-
O	408	418	assistance
O	419	427	programs
O	428	433	would
O	434	440	reduce
O	441	449	underuse
O	450	452	of
O	453	461	adjuvant
O	462	471	therapies
O	471	472	.

O	473	475	We
O	476	485	conducted
O	486	487	a
O	488	498	randomized
O	499	504	trial
O	505	507	of
B-total-participants	508	511	374
O	512	517	women
O	518	519	(
B-intervention-participants	519	522	190
O	523	531	assigned
O	532	544	intervention
O	545	546	[
O	546	549	INT
O	549	550	]
O	550	551	,
B-control-participants	552	555	184
O	556	558	to
B-control	559	564	usual
I-control	565	569	care
O	570	571	[
O	571	573	UC
O	573	574	]
O	574	575	)
B-eligibility	576	580	with
I-eligibility	581	586	early
I-eligibility	586	587	-
I-eligibility	587	592	stage
I-eligibility	593	599	breast
I-eligibility	600	606	cancer
O	607	610	who
O	611	620	underwent
O	621	628	surgery
O	629	636	between
O	637	644	October
O	645	649	2006
O	650	653	and
O	654	660	August
O	661	665	2009
O	665	666	.

O	667	672	After
O	673	680	initial
O	681	686	needs
O	687	697	assessment
O	697	698	,
O	699	713	individualized
O	714	720	action
O	721	726	plans
O	727	731	were
O	732	739	created
O	740	742	to
O	743	750	connect
O	751	754	INT
O	755	763	patients
O	764	768	with
O	769	777	targeted
O	778	785	patient
O	785	786	-
O	786	796	assistance
O	797	805	programs
O	805	806	;
O	807	809	UC
O	810	818	patients
O	819	827	received
O	828	830	an
O	831	844	informational
O	845	853	pamphlet
O	853	854	.

O	855	859	Main
O	860	867	outcome
O	868	876	measures
O	877	881	were
B-outcome-Measure	882	891	receiving
I-outcome-Measure	892	900	adjuvant
I-outcome-Measure	901	910	treatment
O	911	914	and
B-outcome-Measure	915	924	obtaining
I-outcome-Measure	925	929	help
O	929	930	.

O	931	935	High
O	936	941	rates
O	942	944	of
O	945	948	INT
O	949	952	and
O	953	955	UC
O	956	964	patients
B-outcome	965	973	received
I-outcome	974	983	treatment
O	983	984	:
B-iv-bin-percent	985	987	87
I-iv-bin-percent	987	988	%
O	989	992	INT
O	993	999	versus
B-cv-bin-percent	1000	1002	91
I-cv-bin-percent	1002	1003	%
O	1004	1006	UC
O	1007	1012	women
O	1013	1016	who
O	1017	1026	underwent
O	1027	1037	lumpectomy
B-outcome	1038	1046	received
I-outcome	1047	1059	radiotherapy
O	1060	1061	(
O	1061	1062	P
O	1063	1064	=
O	1065	1066	.
O	1066	1068	39
O	1068	1069	)
O	1069	1070	;
B-iv-bin-percent	1071	1073	93
I-iv-bin-percent	1073	1074	%
O	1075	1078	INT
O	1079	1085	versus
B-cv-bin-percent	1086	1088	86
I-cv-bin-percent	1088	1089	%
O	1090	1092	UC
O	1093	1098	women
O	1099	1103	with
O	1104	1112	estrogen
O	1113	1121	receptor
O	1122	1123	(
O	1123	1125	ER
O	1125	1126	)
O	1127	1128	-
O	1128	1136	negative
O	1137	1143	tumors
O	1144	1145	≥
O	1146	1147	1
O	1148	1150	cm
B-outcome	1151	1159	received
I-outcome	1160	1172	chemotherapy
O	1173	1174	(
O	1174	1175	P
O	1176	1177	=
O	1178	1179	.
O	1179	1181	42
O	1181	1182	)
O	1182	1183	;
B-iv-bin-percent	1184	1186	92
I-iv-bin-percent	1186	1187	%
O	1188	1191	INT
O	1192	1198	versus
B-cv-bin-percent	1199	1201	93
I-cv-bin-percent	1201	1202	%
O	1203	1205	UC
O	1206	1211	women
O	1212	1216	with
O	1217	1219	ER
O	1219	1220	-
O	1220	1228	positive
O	1229	1235	tumors
O	1236	1237	≥
O	1238	1239	1
O	1240	1242	cm
O	1243	1251	received
O	1252	1260	hormonal
O	1261	1268	therapy
O	1269	1270	(
O	1270	1271	P
O	1272	1273	=
O	1274	1275	.
O	1275	1277	80
O	1277	1278	)
O	1278	1279	.

O	1280	1284	Many
O	1285	1290	women
O	1291	1299	reported
O	1300	1305	needs
O	1305	1306	:
O	1307	1309	63
O	1309	1310	%
O	1311	1314	had
O	1315	1328	informational
O	1328	1329	;
O	1330	1332	55
O	1332	1333	%
O	1333	1334	,
O	1335	1347	psychosocial
O	1347	1348	;
O	1349	1352	and
O	1353	1355	53
O	1355	1356	%
O	1356	1357	,
O	1358	1367	practical
O	1368	1373	needs
O	1373	1374	.

O	1375	1379	High
O	1380	1385	rates
O	1386	1388	of
O	1389	1392	INT
O	1393	1401	patients
O	1402	1406	with
B-outcome	1407	1412	needs
I-outcome	1413	1422	connected
I-outcome	1423	1427	with
I-outcome	1428	1429	a
I-outcome	1430	1437	program
O	1438	1444	within
O	1445	1446	2
O	1447	1452	weeks
O	1453	1454	(
B-iv-bin-percent	1454	1456	92
I-iv-bin-percent	1456	1457	%
O	1457	1458	)
O	1458	1459	.

O	1460	1462	At
O	1463	1464	6
O	1465	1471	months
O	1471	1472	,
O	1473	1476	INT
O	1477	1480	and
O	1481	1483	UC
O	1484	1489	women
B-outcome	1490	1494	used
I-outcome	1495	1502	patient
I-outcome	1502	1503	-
I-outcome	1503	1513	assistance
I-outcome	1514	1522	programs
O	1523	1525	at
O	1526	1533	similar
O	1534	1539	rates
O	1540	1541	(
B-iv-bin-percent	1541	1543	75
I-iv-bin-percent	1543	1544	%
O	1545	1546	v
B-cv-bin-percent	1547	1549	76
I-cv-bin-percent	1549	1550	%
O	1550	1551	;
O	1552	1553	P
O	1554	1555	=
O	1556	1557	.
O	1557	1559	54
O	1559	1560	)
O	1560	1561	.

O	1562	1567	Women
O	1568	1572	with
O	1573	1586	informational
O	1587	1589	or
O	1590	1602	psychosocial
O	1603	1608	needs
O	1609	1613	were
O	1614	1618	more
B-outcome	1619	1625	likely
I-outcome	1626	1628	to
I-outcome	1629	1636	receive
I-outcome	1637	1641	help
O	1642	1643	(
O	1643	1651	relative
O	1652	1656	risk
O	1657	1658	[
O	1658	1660	RR
O	1660	1661	]
O	1661	1662	,
O	1663	1664	1
O	1664	1665	.
O	1665	1667	77
O	1667	1668	;
O	1669	1671	95
O	1671	1672	%
O	1673	1675	CI
O	1675	1676	,
O	1677	1678	1
O	1678	1679	.
O	1679	1681	51
O	1682	1684	to
O	1685	1686	1
O	1686	1687	.
O	1687	1689	90
O	1690	1693	and
O	1694	1696	RR
O	1696	1697	,
O	1698	1699	1
O	1699	1700	.
O	1700	1702	37
O	1702	1703	;
O	1704	1706	95
O	1706	1707	%
O	1708	1710	CI
O	1710	1711	,
O	1712	1713	1
O	1713	1714	.
O	1714	1716	06
O	1717	1719	to
O	1720	1721	1
O	1721	1722	.
O	1722	1724	61
O	1724	1725	,
O	1726	1738	respectively
O	1738	1739	)
O	1739	1740	.

O	1741	1744	INT
O	1745	1748	and
O	1749	1751	UC
O	1752	1760	patients
O	1761	1769	received
O	1770	1774	high
O	1775	1780	rates
O	1781	1783	of
O	1784	1792	adjuvant
O	1793	1802	treatment
O	1803	1813	regardless
O	1814	1816	of
O	1817	1822	trial
O	1823	1833	assignment
O	1833	1834	.

O	1835	1843	Patients
O	1844	1848	with
O	1849	1855	breast
O	1856	1862	cancer
O	1863	1866	who
O	1867	1874	connect
O	1875	1877	to
O	1878	1886	relevant
O	1887	1894	patient
O	1895	1905	assistance
O	1906	1914	programs
O	1915	1922	receive
O	1923	1929	useful
O	1930	1943	informational
O	1944	1947	and
O	1948	1960	psychosocial
O	1961	1964	but
O	1965	1968	not
O	1969	1978	practical
O	1979	1983	help
O	1983	1984	.
